Pharmacists in Jacksonville, Texas


13 Pharmacists found in Jacksonville
male pharmacist

Anup Chabra


Pharmacist
1729 S Jackson St, Jacksonville, TX 75766
903-284-6256    

female pharmacist

Ariel Nicole Cordova


Pharmacist
921 S. Jackson Street, Jacksonville, TX 75766
903-339-2169    

male pharmacist

Eric Paul Evans


Pharmacist
308 W Larissa St, Jacksonville, TX 75766
903-586-9804    



male pharmacist

Dr. Hermes Jose Ortiz, PHARM D., R.PH


Pharmacist
1329 S Jackson St, Jacksonville, TX 75766
903-339-7074     903-339-7075

male pharmacist

Dr. Kebba S Camara, PHARMD


Pharmacist
1329 S Jackson St, Jacksonville, TX 75766
903-339-7074    

female pharmacist

Kimberly Joy Canon


Pharmacist
210 E Cherokee St, Jacksonville, TX 75766
903-586-2284     903-586-2285

female pharmacist

Lauren Lee, PHARM D


Pharmacist
1311 S Jackson St, Jacksonville, TX 75766
903-586-1164    

female pharmacist

Leslie Jean Neal, RPH


Pharmacist
210 E Cherokee St, Jacksonville, TX 75766
903-586-2284     903-586-2285

female pharmacist

Mia Ziedan


Pharmacist
1311 S Jackson St, Jacksonville, TX 75766
903-586-1164    

male pharmacist

Oluwasegun Oyenpemi, PHARMD


Pharmacist
1311 S Jackson St, Jacksonville, TX 75766
903-589-3434    

male pharmacist

Dr. Ravish Nitinkumar Shah, PHARMD


Pharmacist
1729 S Jackson St, Jacksonville, TX 75766
903-284-6256     903-284-6243

male pharmacist

Dr. Robert Meeks


Pharmacist
308 W Larissa St, Jacksonville, TX 75766
903-586-9804    

male pharmacist

Tim Lyn Worsham, RPH


Pharmacist
1466 County Road 3405, Jacksonville, TX 75766
903-284-8325    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.